ClinicalTrials.govpublic full text
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy
cancer of ovary, pancreatic ductal adenocarcinoma, solid tumors, metastatic, inoperable, brca mutations, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825279
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.